; (spon. by S. Inoue), Children's Hospital of Michigan (CHI), Detroit, Michigan 48201.
group (36) varied from 0.4 to 3.65 mgl? < ; 1.55 mg + .79). 4 had elevated levels of B m 63mg/l,? +2SD) at a time when CSF was free of leukemic cel?s. Three eventually developed CNS leukemia 2 mos., 8 mos., and 4 yrs. later. The CSF B m level at the time of overt CNS relapse in 6 AL children varied2from 0.93 -5 mgll (f 3.18 + 1.78). This differed significantly (p: C.001) from the CNS prophylaxis group. B m level was > 3 mg/l in 516. These data confirm the prior obiervations of others that CSF B m levels 2 are elevated during CNS relapse. Thus elevated levels may indicate impending relapse. Prophylactic IT MTX in itself does not appear to significantly alter the normal CSF B2m levels. A marked increase in WBC count with blast cell predominance in blood is a well known hematological abnormality seen in neonates with Down's syndrome. Differentiation of true leukemia from a transient leukemoid reaction is often difficult. Examination of in vitro colony formation and maturation by circulating stem cells may be helpful in separating the two entities. We studied a newborn infant with trisomy 21 Down's syndrome who had juandice, 5 cm palpable liver and 1 cm palpable spleen. The Hb, WBC and platelet count at day 3 of life were 12.5 gm %, 62,300 with 58% blasts and 90.5x1031mm3, respectively. Blood group incompatibility and intrauterine infections were excluded. The marrow showed 17% blasts. Prominent large basophilic granules were present in late myeloid precursors. The patient was simply observed. During the next 6 weeks the hematological picture returned to normal. Cultures of blood stem cells using the methylcellulose system were done on two occasions at day 9 of age (WBC 38.5~103, 47% blasts), and at day 26 of age (WBC 17.7~103, 6% blasts). The first blood formed 1,525 myeloid and 213 erythroid, and the second blood 256 myeloid and 17 erythroid colonies/ml of blood, respectively. No maturational difficiency was observed by cytological study of representative colonies. This normal maturation pattern is consistent with the spontaneous resolution of the clinical picture. The technique may be a useful tool in predicting the outcome. These neuropsychological and electrophysiological t e s t s are valuable i n the evaluation o f the long-term nervous system sequel ae o f chi1 dhood leukemia and i t s treatment.
MAGNESIUM SULPHATE (MgS04): FURTHER CONFUSION IN THE
MGS04 is frequently used as a tocolytic agent and inthetreatment of toxemia of pregnancy. Thus, MgS04 is a common antenatal drug administered to the very low birth weight infant (VLBW i.e.
< 1500 gms) .
In a prospective study of non septic VLBW infants during the past 12 months mean corrected total white blood cell counts (WBC) during the first 24 hours of life were significantly depressed among infants exposed to MgS04 in utero (N=42, mean gestational age=29 weeks,meanwt.=1082, mean5'Apgar Score=7.0)in comparison to those whose mothers did not receive the drug. (N=45,mean gestational age=29.1 weeks,meanwt.=1070gms,mean 5'Apgar Score-7.0). The mean corrected WBC were 9.3xld vs 12.0xld ( p~ .037). Total neutrophil(TNC)werefound to be depressed in MgS04 group in comparison to the non MgS04 group with mean TNC 4166 vs 6008.
More importantly, the incidence of leukopenia(WBC C 6000) was significantly higher in the MgS04 treated group, 38% vs 13.3% (p 4.05)but did not differ from that seen in a matched group of VLBW infants with blood culture proven sepsis, 38% vs 33%.
These data lead us to conclude that MgS04 administered to the mother may result in depression of the WBC and TNC in her infant. In the presence of MgS04, leukopenia and neutropenia cannot be validly interpreted as evidence of infection in the newborn. Fifteen patients with acute lymphoblastic leukemia in long t e n remission were studied. Nine patients were in remission for 6 months to 4 years following 5 years of chemotherapy and 6 patients were 3 years into remission and receiving maintenance chemotherapy. T cells were enumerated by the E-sheep-red-cell rosette method, subpopulations of T cells (Ty and TP) by ox-red cell IgM and IgG rosette formation, B cells by membrane immunoglobulin fluorescence. Mitogen stimulated cultures used phytohemagglutinin, concanavalin A and pokeweed mitogen. Immunoglobulin synthesis was estimated by a radioimmunoassay of the supernatant of pokeweed mitogen stimulated cultures. The total leukocyte count was significantly decreased (p<0.01), the absolute lymphocyte count was comparable (p>0.1). T cells were significantly decreased (p<0.005). Subpopulations of T cells, Ty and TII cells showed significantly lowered numbers, more so in the patients who were receiving chemotherapy, (pc0.05). Mitogen stimulated cultures in 3 patients showed normal to increased H3 thymidine incorporation in fetal calf serum, allogenic serum and autologous serum. Preliminary studies detected low immunoglobulin levels in pokeweed mitogen stimulated supernates of 2 patients tested. 
DECREASED NUMBERS OF T CELLS AND SUBPOPULATIONS, INCREASED MITOGEN REACTIVITY AND DEFECTIVE IMMUNO-
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